Floatz logo

Dhea

Vaginal Dryness

Hadassah Medical OrganizationPhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Vaginal Dryness cohort.

Asset / SponsorPhaseRating
Prasterone
University Hospital, Ghent
Phase 4BB
Estriol
ITF Research Pharma, S.L.U.
Phase 2BB
PILOCARPINUM
Alliance for Clinical Trials in Oncology
Phase 3BB
AUTOLOGOUS CONDITIONED PLASMA
University of Miami
Phase 2B
Polycarbophil
University of Arkansas
Phase 2CCC
Prasterone
University of Arkansas
Phase 2CCC
TESTOSTERONE UNDECYLATE
Creighton University
Early Phase 1CC
Promestriene
Federal University of São Paulo
N/AD

Same molecule, other indications

Dhea is also rated in:

Urinary IncontinenceDormant
B
Indicative ·
57 / 100
View asset →
breast cancerDormant
CCC
Indicative ·
48 / 100
View asset →
Sexual SatisfactionDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →